Nicotinamide pre-treatment ameliorates NAD(H) hyperoxidation and improves neuronal function after severe hypoxia.
Neurobiol Dis
; 62: 469-78, 2014 Feb.
Article
en En
| MEDLINE
| ID: mdl-24184921
Palabras clave
ACSF; AIF; Brain; CA1; DG; H; HSD; Hippocampus; Hypoxia; NAD(+); NAD(H); NAM; Nicotinamide; PARP-1; ROI; ROS; SIRT-1; SR; Spreading depression; TCA cycle; apoptosis-inducing factor; artificial cerebrospinal fluid; cornu ammonis region 1; dentate gyrus; fEPSP; field excitatory post-synaptic potential; hypoxia; hypoxic spreading depression; nicotinamide; nicotinamide adenine dinucleotide; poly(ADP-ribose) polymerase-1; reactive oxygen species; region of interest; reox; reoxygenation; silent mating-type information regulation 1; stratum radiatum; total NAD(+) and NADH content; tricarboxylic acid cycle
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Hipoxia Encefálica
/
Niacinamida
/
Fármacos Neuroprotectores
/
Hipocampo
/
NAD
Tipo de estudio:
Prognostic_studies
Límite:
Animals
Idioma:
En
Revista:
Neurobiol Dis
Asunto de la revista:
NEUROLOGIA
Año:
2014
Tipo del documento:
Article